Bank Of America Corp Genenta Science S.P.A. Transaction History

Bank Of America Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$3.93 - $5.88 $1,347 - $2,016	343 New	343 $1,000
Q2 2022 Aug 12, 2022	SELL	$5.39 - $8.26 $161 - $247	-30 Reduced 7.3%	381 $0
Q1 2022 May 16, 2022	BUY	$5.43 - $11.4 $2,231 - $4,685	411 New	411 $3,000

Ticker GNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,216,900
Market Cap $72.3M
Description
Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.